These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Bcl-2 expression as a predictor of chemosensitivities and survival in small cell lung cancer. Takayama K; Ogata K; Nakanishi Y; Yatsunami J; Kawasaki M; Hara N Cancer J Sci Am; 1996; 2(4):212-6. PubMed ID: 9166534 [TBL] [Abstract][Full Text] [Related]
23. Prognostic evaluation of the expression of p53 and bcl-2 oncoproteins in patients with surgically resected non-small cell lung cancer. Lai RS; Wang JS; Hsu HK; Chang HC; Lin CH; Lin MH Jpn J Clin Oncol; 2002 Oct; 32(10):393-7. PubMed ID: 12451034 [TBL] [Abstract][Full Text] [Related]
24. The significance of frequent and independent p53 and bcl-2 expression in large-cell neuroendocrine carcinomas of the lung. Jiang SX; Kameya T; Shinada J; Yoshimura H Mod Pathol; 1999 Apr; 12(4):362-9. PubMed ID: 10229500 [TBL] [Abstract][Full Text] [Related]
25. Relationship of Fas, FasL, p53 and bcl-2 expression in human non-small cell lung carcinomas. Li Y; Xu KP; Jiang D; Zhao J; Ge JF; Zheng SY Int J Clin Exp Pathol; 2015; 8(11):13978-86. PubMed ID: 26823709 [TBL] [Abstract][Full Text] [Related]
26. Immunohistochemical detection of bcl-2 protein in adenocarcinoma and non-neoplastic cellular compartments of the lung. Rao SK; Krishna M; Woda BA; Savas L; Fraire AE Mod Pathol; 1996 May; 9(5):555-9. PubMed ID: 8733771 [TBL] [Abstract][Full Text] [Related]
27. Non-small cell lung carcinoma: cyclin D1, bcl-2, p53, Ki-67 and HER-2 proteins expression in resected tumors. Radović S; Babić M; Dorić M; Hukić A; Kuskunović S; Hadzismajlović A; Serdarević F Bosn J Basic Med Sci; 2007 Aug; 7(3):205-11. PubMed ID: 17848143 [TBL] [Abstract][Full Text] [Related]
28. Immunohistochemical detection of Bcl-2 protein in small cell carcinomas. Yan JJ; Chen FF; Tsai YC; Jin YT Oncology; 1996; 53(1):6-11. PubMed ID: 8570134 [TBL] [Abstract][Full Text] [Related]
29. Small cell carcinomas of the lung express the Bcl-2 protein. Ben-Ezra JM; Kornstein MJ; Grimes MM; Krystal G Am J Pathol; 1994 Nov; 145(5):1036-40. PubMed ID: 7977636 [TBL] [Abstract][Full Text] [Related]
30. DNA ploidy and proliferative activity in bcl-2 expressed non-small cell lung cancer. Kim YC; Park KO; Kim HJ; Choi IS; Park CS; Juhng SW Korean J Intern Med; 1996 Jun; 11(2):101-7. PubMed ID: 8854645 [TBL] [Abstract][Full Text] [Related]
31. Prognostic value of immunohistochemical staining of p53, bcl-2, and Ki-67 in small cell lung cancer. Paik KH; Park YH; Ryoo BY; Yang SH; Lee JC; Kim CH; Ki SS; Kim JM; Park MJ; Ahn HJ; Choi W; Chung JH J Korean Med Sci; 2006 Feb; 21(1):35-9. PubMed ID: 16479062 [TBL] [Abstract][Full Text] [Related]
32. Immunocytochemical study of RAS oncoprotein in cytologic specimens of primary lung tumours. Koutselini H; Kappatou G; Yiagnisis M; Field JK; Spandidos DA Anticancer Res; 1990; 10(3):597-603. PubMed ID: 2164347 [TBL] [Abstract][Full Text] [Related]
33. Vascular endothelial growth factor, wild-type p53, and angiogenesis in early operable non-small cell lung cancer. Giatromanolaki A; Koukourakis MI; Kakolyris S; Turley H; O'Byrne K; Scott PA; Pezzella F; Georgoulias V; Harris AL; Gatter KC Clin Cancer Res; 1998 Dec; 4(12):3017-24. PubMed ID: 9865915 [TBL] [Abstract][Full Text] [Related]
35. The preliminary estimation of bcl-2, bcl-X(L) and p53 genes expression in locally advanced non-small cell lung cancer. Karczmarek-Borowska B; Filip A; Zdunek M; Korobowicz E; Wojcierowski J; Korszeń-Pilecka I; Furmanik F Ann Univ Mariae Curie Sklodowska Med; 2003; 58(1):124-31. PubMed ID: 15314971 [TBL] [Abstract][Full Text] [Related]
36. [Effect of paraneoplastic rheumatic syndrome in lung cancer patients on tumor expression of BCL-2]. Lysenko SA Vopr Onkol; 2013; 59(6):731-4. PubMed ID: 24624782 [TBL] [Abstract][Full Text] [Related]
37. Expression of apoptosis regulatory proteins of the Bcl-2 family and p53 in primary resected non-small-cell lung cancer. Borner MM; Brousset P; Pfanner-Meyer B; Bacchi M; Vonlanthen S; Hotz MA; Altermatt HJ; Schlaifer D; Reed JC; Betticher DC Br J Cancer; 1999 Feb; 79(5-6):952-8. PubMed ID: 10070896 [TBL] [Abstract][Full Text] [Related]
38. Risk of recurrence in patients with surgically resected stage I non-small cell lung carcinoma: histopathologic and immunohistochemical analysis. Poleri C; Morero JL; Nieva B; Vázquez MF; Rodríguez C; de Titto E; Rosenberg M Chest; 2003 Jun; 123(6):1858-67. PubMed ID: 12796161 [TBL] [Abstract][Full Text] [Related]
39. Bcl-2 protein expression in lung cancer and close correlation with neuroendocrine differentiation. Jiang SX; Kameya T; Sato Y; Yanase N; Yoshimura H; Kodama T Am J Pathol; 1996 Mar; 148(3):837-46. PubMed ID: 8774138 [TBL] [Abstract][Full Text] [Related]
40. Frequent loss of Fas expression and function in human lung tumours with overexpression of FasL in small cell lung carcinoma. Viard-Leveugle I; Veyrenc S; French LE; Brambilla C; Brambilla E J Pathol; 2003 Oct; 201(2):268-77. PubMed ID: 14517844 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]